BSECompany Update5 Aug 2026 · 5 Aug 2026, 05:57 pm
Re-appointment of Mr. Hemang Shah as Executive Director of the Company, Subject to approval of Shareholders in enuing AGM.
Bharat Parenterals Ltd · 541096
✦ AI SummaryMgmt Change
Bharat Parenterals Ltd has announced the re-appointment of Mr. Hemang Shah as Executive Director of the company, subject to shareholder approval at the upcoming AGM.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Bharat Parenterals Ltd - 541096 - Announcement under Regulation 30 (LODR)-Change in Directorate
Attachments (1)
📄pdf
Download →
262faf1c-a3eb-4deb-b3ca-31bee66d8823.pdf
View document text
Date: August 05, 2026
The Corporate Relationship Department
BSE Limited
Phiroze Jeejeebhoy Towers,
Dalal Street, Mumbai-400001.
Script Code: 541096
Subject: Intimation under Regulation 30 of the SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015- Re-Appointment of Mr. Hemang Shah
As An Executive Director of the Company.
Pursuant to Regulation 30 of the SEBI LODR Regulations, we wish to inform you that the
Board of Directors of the Company at its meeting held today i.e. August 05, 2026 has inter
alia based on recommendation of Nomination and Remuneration Committee, Audit
Committee and subject to the approval of shareholders at the ensuing Annual General
Meeting, approved the re-appointment of Mr. Hemang Shah (DIN: 03024324) as an
Executive Director of the Company for the term of 5 (five) consecutive years with effect
from July 02, 2026 to upto July 01, 2031.
Further, we wish to inform you that the Nomination and Remuneration Committee and the
Board while considering his Re-appointment, have verified that all above said person is not
debarred from holding the office of Director pursuant to any order of MCA/SEBI or of any
other authorities.
Further, the details as required in terms of Regulation 30 read with Schedule III of the SEBI
LODR Regulations and SEBI Master Circular bearing No. HO/49/14/14(7)2025-
CFDPOD2/I/3762/2026 dated January 30, 2026 is provided in Annexure A.
The above information will be available on the Company's website at www.bplindia.in.
Kindly take the above information on record and acknowledge the receipt.
Thanking You.
Yours Faithfully
For, Bharat Parenterals Limited
Mr. Sharmin Soni
Company Secretary & Compliance Officer
ICSI Membership Number: A-75694
Place: Vadodara
Annexure A
Sr. Particular Details
1 Name Hemang Jayendrabhai Shah
2 Reason for Change viz., appointment, Re- appointment of Mr. Hemang
Re-Appointment resignation, removal, Shah as an Executive Director of
death or otherwise the Company.
3 Date of appointment/ Re-Appointment Date of Re- Appointment:
/cessation (as applicable) & term of July 02, 2026
appointment Term of Re- Appointment:
5 (Five) consecutive years with
effect from July 02, 2026 upto July
01, 2031
4 Brief Profile (in case of appointment) Mr. Hemang Shah is Bachelor of
Commerce and also holds degree
of MSW. He is associated with the
Company from more than last Two
Decade and has played a pivotal
role in the growth and
development of the Company.
Mr. Shah has more than 30 years
of reach experience.
5 Disclosure of relationships between Mr. Hemang Shah is not related to
directors in case of appointment of a any Director of the Company.
director.